Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Microbiology MBBS > Bloodstream: Hemoflagellates, lymphatic filariasis > Flashcards

Bloodstream: Hemoflagellates, lymphatic filariasis Flashcards

You may prefer our related Brainscape-certified flashcards:
Biology 101 flashcards
1
Q

Hemoflagellates

A

Flagellated protozoa that are found in peripheral blood circulation. Eg., leishmania and trypanosoma (transmitted by insect vector)
Oval to elongated body, nucleus and a single flagellum arising from kinetoplast (multiple mDNA)
Axoneme is present
4 morphological forms: amastigote, promastigote, epimastigote, trypomastigote

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Leishmaniasis

A

By obligate intercellular protozoa Leishmania, which primarily affects the reticulo endothelial system
Transmitted by female sandfly bite
Three forms: visceral leishmaniasis, PKDL, cutaneous forms
Two sub genera: L leishmania and vienna

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Visceral leishmania

A

Caused by Leishmania donovani
Promastigote - infective form in alimentary canal of female sandfly
Pentad: 🤒, progressive weight loss, hepatosplenomegaly, pancytopenia and hypergammaglobulinemia
Death occurs due to superimposed infections, anemia and hemorrhages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Life cycle of Leishmania donovani in human

A

In humans:

  1. Promastigotes are phagocytosed by the skin macrophages and turn into
  2. Amastigotes which multiply within macrophages causing cell rupture and are released into circulation.
  3. Amastigotes leave the circulation to liver, spleen and bone marrow and invade invade RES cells like macrophages, endothelial cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Life cycle of Leishmania donovani in sandfly

A
  1. During blood meal, amastigotes are ingested
  2. They reach midgut, then ransform into promastigote
  3. Multiplication and then migration to foregut
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pathogenicity of visceral leishmania

A
  1. Phagocytosis of promastigotes is facilitated by binding of its surface antigens such as gp-63 and LPG lipophosphoglycan
  2. LPG - principle virulence factor preceding phagosome maturation and protects the parasite against phagolysis
  3. GPI protects from phagolysis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Visceral Leishmaniasis

host response

A
  1. TH-1 response:
    • CMI ➡️ macrophage activation ➡️ amastigotes killed
    • observed in cutaneous leishmaniasis and patients after recovery/treated for VL
    • delayed type hypersensitivity developed
  2. TH-2:
    • polyclonal B cell activation ➡️ hypergammaglobulinemia
    • observed in patients with active VL and diffuse CL
    • negative for leishmanin skin test
    • pathogenesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Visceral leishmaniasis Kala azar

Clinical features

A
  1. Pentad: 🤒, progressive weight loss, hepatosplenomegaly, pancytopenia and hypergammaglobulinemia
  2. Lymphadenopathy and leishmanoma in African
  3. Hyperpigmentation in Indian
  4. Pedal edema and ascites in advanced illness
  5. Mucosal lesions in African
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Post-kala-azar dermal leishmaniasis

PKDL

A

Non-ulcerative lesson of skin in some patients of VL following treatment with antimonials
Aggravated on exposure to sunlight
Develops as hypopigmented macule near mouth which spreads to face, arms, trunk and finally becomes nodules resembling leprosy
Conjunctivitis and uveitis in some

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Post-kala-azar dermal leishmaniasis
PKDL
Diagnosis and treatment

A 
Diagnosis: 
1. Amastigotes in nodular lesions
2. Direct agglutination test DAT
3. Antibodies to rK39 antigen
DoC: amphotericin B
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Leishmaniasis

Lab diagnosis

A
  1. Microscopy
  2. Culture
  3. Antibody detection
  4. Antigen detection
  5. Molecular method
  6. Leishmanin test
  7. Animal inoculation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Leishmaniasis

microscopy and culture

A

Microscopy: Giemsa staining detects LD bodies
1. Splenic aspiration: Most sensitive
2. Bone marrow aspiration: Lymph node aspiration
3. Liver biopsy
4. Peripheral blood smear: in HIV
Culture: species investigation and drug sensitivity
1. NNN medium
2. Schneider’s liquid medium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Leishmaniasis

antibody tests

A
  1. Direct agglutination test:
    100% sensitive and specific, simple, rapid
    Ab persist for 5 years
  2. Immunochromatographic test ICT:
    Similar to DAT, but with less sensitivity in East Africa and HIV patients
  3. ELISA and IFA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Leishmaniasis

Antigen detection

A 
Latex agglutination test for Ag in urine
Good specificity but variable
More useful in:
1. HIV-VL co-infection
2. As a prognostic marker
3. Indicating active infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Leishmanin test

Montenegro test

A

Skin test to detect delayed hypersensitivity to a suspension of killed L. donovani promastigote injected intradermally
Positive in people with good CMI
Negative even active VL and diffuse CL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment of visceral leishmaniasis

A
  1. Pentavalent antimonials
  2. Liposomal amphotericin B: current DoC
  3. Miltefosine
  4. Paromomycin
  5. Immunotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Leishmaniasis

control measures

A
  1. Personal prophylaxis using insect repellents or bed nets
  2. Control of canine or rodent reservoir
  3. Phlebotomus does not fly high and is nocturnal. So 😴 at higher floors can prevent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Chaga’s disease

Life cycle of T. cruzi in humans

A
  1. Rubbing of vector feces on abraded skin
  2. Trypomastigotes are carried to various tissues
  3. Amastigotes form and multiply intracellularly in RES, muscles and nervous tissue
  4. Trypomastigotes are reformed in peripheral blood (extracellular)
  5. Invasive ones migrate to many organs and short stubby forms are ingested by reduviid bugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Chaga’s disease

vector cycle

A
  1. In gut of reduviid bugs, the trypomastigotes transform into epimastigotes
  2. In hindgut, it is further developed into metacyclic trypomastigotes
  3. Excreted in feces
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Classification of trypanosomes

A

Trypanosomes are hemoflagellates that reside in peripheral blood and tissues of host
1. African trypanosomes:
T. brucei complex transmitted by vector tse-tse fly
African sleeping sickness
2. American trypanosomes:
T. cruzi transmitted by reduviid/triatomine bug
Chaga’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Pathogenesis of Chaga’s disease

A 
1. Early stage disease
• Chagoma and Romana’s sign
2. Acute Chaga’s disease
3. Indeterminate Chaga’s disease
4. Chronic Chaga’s disease:
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Early stage of Chaga’s disease

A

Characterized by:

  1. Chagoma: painful subcutaneous nodule at the site of deposition of bug feces (face,…)
  2. Romana’s sign: it causes unilateral painless edema of the eyelid and conjunctivitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Acute and indeterminate Chaga’s disease

A

Acute Chaga’s disease:
In few early stage patients; 🤒, hepatosplenomegaly, lymphadenopathy
Indeterminate Chaga’s disease:
Asymptomatic, lasting for years to decades

24
Q

Chronic Chaga’s disease

manifestations

A

The parasite multiplies in the muscles (cardiac and GIT) and nervous tissue
1. Cardiac form:
Dilated cardiomyopathy, arrhythmia, thromboembolism
2. Gastrointestinal form:
Megaesophagus and megacolon

25
Q

Chronic Chaga’s disease

Mechanism

A

Molecular mimicry ➡️ ADCC

HIV and HTLV-II infected people are at higher risk of reactivation of underlying T. cruzi infection

26
Q

Congenital trypanosomiasis

A

Rarely T. cruzi can be transmitted transplacentally both in acute and chronic stages. It manifests as:

  1. Low birth weight, stillbirth
  2. Rarely myocarditis and neural alterations
27
Q

Chaga’s disease

lab diagnosis

A 
1. Peripheral blood microscopy:
 Thick and thin
2. Culture for epimastigote forms
3. Ab detection for chronic
4. Ag from serum or urine for acute and congenital
5. Molecular method: most effective
6. Animal inoculation
7. Xenodiagnosis
28
Q

Treatment for Chaga’s disease

A

Unsatisfactory
1. Acute:
Benznidazole DoC (Nifurtimox/ allopurinol)
2. Chronic:
Drugs ineffective with ADR
Surgery for megacolon, pacemakers for cardiac,…

29
Q

Prophylaxis for Chaga’s disease

A
  1. Residual insecticides
  2. Health education
  3. Measures to reduce insect exposure
  4. Housing improvement
30
Q

African sleeping sickness

A

By Trypanosoma brucei through tsetse fly inoculation into skin
Two types
Infective form metacyclic trypomastigote
It undergoes periodic antigen variation ➡️ changes in Variable Surface Glycoprotein VSG ➡️ evades immune response

31
Q

African sleeping sickness

types

A 
1. T. brucei gambiense:
 West African of humans primarily
 Chronic course with slow progression
 Winterbottom sign
2. T. brucei rhodesiense:
 East African of cattle primarily
 Rapid progression with early death
 High virulence and parasitemia
32
Q

African sleeping sickness

life cycle in humans

A
  1. Site of inoculation, they transform into long slender trypomastigote
  2. Multiplication by binary fission
  3. Non-dividing short stumpy trypomastigote which invade bloodstream
  4. The rest migrate to other organs
33
Q

African sleeping sickness

life cycle in tsetse fly

A
  1. Short stumpy trypomastigote becomes long slender
  2. The trypomastigote then becomes epimastigote
  3. Then metacyclic trypomastigote is formed- infective form
34
Q

African sleeping sickness
stages of disease
treatment

A

Stage 1: hemolymphatic
Stage 2: CNS invasion
Drugs used are pentamidine and suramin (eflornithine, melarsoprol)
Treatment is based on the type (West or East) and the presence of CNS invasion.

35
Q

African sleeping sickness

stage I: hemolymphatic stage

A
  1. Trypanosomal chancre:
    Self limited lesion week after the bite
  2. Asymptomatic period:
    A few months
  3. Systemic febrile illness:
    Dissemination of parasites in lymphatics and bloodstream
    • remittent irregular 🤒 with night sweats
    • Winterbottom’s sign: post. cervical lymphadenopathy of West
36
Q

African sleeping sickness

stage II CNS invasion

A

Progressive chronic meningocephalitis

Daytime somnolence with restless and sleepless nights

37
Q

African sleeping sickness

lab diagnosis

A
  1. Direct microscopy
  2. Ag from serum and CSF: staging and prognosis
  3. Ab from serum and CSF
  4. Molecular methods: PCR, FISH
  5. Culture into KIVI
  6. Animal inoculation in 🐁 for East
38
Q

African sleeping sickness

Microscopy

A 
1. Blood: trypomastigotes
 Wet mount, thin/thick smear, concentration method
2. CSF examination: for invasion
• trypomastigotes
• WBC >20/μL
3. Lymph nodes for West
Others are chancre fluid, bone marrow
39
Q

African sleeping sickness

antibody tests

A
  1. Card agglutination test:
    For trypanosomes b to detect Ab to VSG antigen
  2. Semi-quantitative ELISA:
    Using VSG antigen of T. brucei gambiense
40
Q

Types of filariasis

A
  1. Lymphatic filariasis:
    Eg., W. bancrofti, Brugia malayi, B. timori
  2. Cutaneous and ocular filariasis:
    Eg., Loa Loa, Onchocerca volvulus, Mansonella
41
Q

Forms of filarial worms 🪱

A 
1. Adult worm:
 Lymphatic filariasis
2. Larvae:
 1st stage - microfilaria
 3rd stage - filariform larva
3. Microfilaria:
 Can cause tropical pulmonary eosinophilia, but usually non-pathogenic
42
Q

Bancroftian filariasis

host, vector and infective form

A

Intermediate host: mosquito 🦟
Principle vector: Culex quinquefasciatus
Infective form: L3 filariform larva

43
Q

Bancroftian filariasis

human cycle

A
  1. L3 deposited in skin by 🦟 bite
  2. Penetrate skin ➡️ enter lymphatic vessels ➡️
  3. Local lymph nodes ➡️ adult worms upto 20 years,…
  4. Fertilization ➡️ microfilaria upto 1 yr
  5. Pre-patent period: b/w infection and diagnosis
    82-142 days
44
Q

Bancroftian filariasis

🦟 cycle

A
  1. Culex bites at 🌃 and Aedes bites at 🏙
  2. Microfilaria comes out of sheath ➡️ penetrates stomach wall ➡️
  3. Migrate to thoracic muscle ➡️ molt twice to L3
  4. Migrate to proboscis
    Takes 7-21 days
45
Q

Bancroftian filariasis

pathogenesis when 🪱 is alive

A 
Related to migration of adult 🪱:
1. Lymphatic dilation
2. Thickening of vessel walls 
Related to antigens and toxic metabolites
2° bacterial and fungal infections
Host inflammatory response:
1. Infiltration
2. 🔼 tortuosity of vessels and damage to valves
46
Q

Bancroftian filariasis

pathogenesis after death of 🪱

A

🔼 granulomatosis and fibrosis of lymph vessels ➡️ lymphatic obstruction

47
Q

Endosymbiosis b/w W. bancrofti and Wolbachia (rickettsia)

A

W. bancrofti is found to be infected with Rickettsia called Wolbachia and maintain an endosymbiotic relationship

48
Q

Microfilaremia

A

Increases with age
Starts at 5 years and peaks at >30 years
🧔🏽‍♂️>👩🏽‍🦰 because of hormonal factors

49
Q

Bancroftian filariasis

host immune response

A

Early infection:
Amicrofilaremic individuals- both TH1 and TH2
Microfilaremic individuals:
TH1🔽 & TH2🔼 so 🔼 IL-4,5,13,10, profound eosinophilia, IgE 🔼, 🪱 specific IgG-4
Chronic filariasis:
progression- IL-4,5,13,10
🪱 specific IgG-1,2,3

50
Q

Bancroftian filariasis

clinical manifestations

A
  1. Lymphatic filariasis: 4 stages
    • endemic normal
    • asymptomatic microfilaremia
    • acute adenolymphangitis
    • chronic filariasis
  2. Tropical pulmonary eosinophilia TPE or occult filariasis
  3. Immune complex mediated manifestations
51
Q

Bancroftian filariasis

endemic normal

A 
0-50% of normal people residing in endemic areas
Not infected
Reasons:
1. Insufficient exposure
2. Resistance
3. Prepatent period
52
Q

Bancroftian filariasis

Asymptomatic microfilaremia

A

In endemic areas
Do not have symptoms of filarial infection, but microfilaria present
1. Microscopic hematuria, proteinuria
2. Dilated and tortuous lymphatics
3. Filarial dance 💃 sign:
Ultrasound shows adult 🪱 in scrotal lymphatics

53
Q

Bancroftian filariasis
Acute filariasis or
Acute lymphangitis

A
  1. Filarial fever (high grade)
  2. Lymphatic inflammation: nodes and vessels
    • lower extremities more common
    • lymph nodes: firm, discrete, tender, enlarged
    • male genital organs: funiculitis, epididymitis, orchitis (not in Brugian)
  3. Transient local edema
    Reversible (on raising) pitting edema
  4. Dermatolyphangitis:
    Plaque like lesions over nodes
    In Brugian episodes more frequent and abrupt
54
Q

Bancroftian filariasis

Chronic filariasis

A 
It develops 10-15 years later
🪱 dead ➡️ granuloma and fibrosis ➡️ severe lymphatic obstruction ➡️ pedal edema
1. Hydrocele: M/C
 Straw colored fluid in tunica vaginalis 
2. Elephantiasis:
 Lower limb, arm, vulva, breast
3. Chronic funiculitis
4. Chyluria
55
Q

Bancroftian filariasis
Tropical pulmonary eosinophilia or
Occult filariasis

A

Hypersensitivity to filarial antigen
Rapidly cleared from blood, filtered, lodged and destroyed in 🫁
Microfilaria not detected in blood

56
Q

Bancroftian filariasis

Immune complex mediated manifestations

A

Kidneys: nephrotic syndrome, hematuria, proteinuria
Joints: filarial arthritis of knee & ankle

Microbiology MBBS (16 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions